姓名：马娟 性别：女 职称：主任技师、副教授 招生院所：附属世纪坛医院 招生类型：科学学位(硕) 招生专业：临床检验诊断学(硕) 研究方向名称：肿瘤标志物筛选及肿瘤免疫的研究 电子信箱：atiger10@163.com


社会任职
1. 中国医药质量管理协会细胞治疗质量控制与研究专业委员会委员
2. 北京大学医学部医学检验学学系第三届委员会委员
3. 中华医学会检验医学分会第十届青年委员会委员
个人简历
1. 199109-199607:中国医科大学 医学学士
2. 199809-200107:中国医科大学 医学硕士
3. 200304-200703:日本顺天堂大学 医学博士
4. 200704-201109:东京医科大学难治性免疫疾病研究中心 博士研究员
5. 201110-201505:中国科学院微生物研究所 副研究员
6. 201506-201906:首都医科大学附属北京世纪坛医院 副主任技师、副教授
7. 201907-:首都医科大学附属北京世纪坛医院 主任技师
重要学术论文
1. X Sun, Y Yu, L Ma, X Xue, Z Gao, J Ma*, M Zhang.T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting. Investigational New Drugs . 2019,July3:doi: 10.1007/s10637-019-00819-y.SCI
2. J Ma*,T Shang，P Ma，X Sun，J Zhao，X Sun，M Zhang*.Bispecific anti-CD3 × anti-B7-H3 antibody mediates T-cell cytotoxic ability to human melanoma in vitro and in vivo. Investigational New Drugs. 2019,37（5）:1036-1043.SCI
3. 马娟，高振奎， 孟倩， 李佳， 孙喜明， 赵瑾， 张曼*.80例血液病骨髓染色体核型分析. 标记免疫分析与临床. 2018,25(10):1440-1444,1459.
4. J Ma*, J Ge, X Xue, W Xiu，P Ma, X Sun, M Zhang*.Targeting bladder cancer by using activated T cells armed with bispecific antibodies. Oncology Reports . 2018,39(3):1245-1252.SCI
5. J Ma#*, P Ma#, C Zhao#, X Xue, H Han, C Liu, H Tao, W Xiu, J Cai, M Zhang*.B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy. Oncotarget. 2016,7（20）:29480-29491.SCI
6. P Ma#，Q He#，W Li，X Li，H Han，M Jin，C Liu，H Tao，J Ma*, B Gao*.Anti-CD3 × EGFR bispecific antibody redirects cytokine-induced killer cells to glioblastoma in vitro and in vivo. Oncology Reports. 2015,34 (5):2567-2575.SCI
7. 马娟，李佳，张曼*.检验专科医师规范化培训染色体核型分析的培训内容与要求探讨. 国际检验医学. 2015,36（22）:3358.
8. J Ma#*, H Han#, L Ma, C Liu, P Ma, X Xue, X Li, H Tao.The immunostimulatory effects of retinoblastoma cell supernatant on dendritic cells. Protein and cell. 2014,5 (4):307-316 .SCI
9. H Han#, J Ma#*, K Zhang#, W li, C liu, X Xue, Y Zhang, G Zhang, P Ma, L Wang, G Zhang, H Tao, B Gao*.Bispecific anti-CD3×anti-HER2 antibody mediates T cell cytolytic activity to HER2-positive colorectal cancer in vitro and in vivo. International journal of oncology . 2014,45 (6):2446-2454 .SCI
10. J Ma, H Han, D Liu , W Li , H Feng , X Xue , X Wu , G Niu , G Zhang , Y Zhao , C Liu, H Tao , B Gao*.HER2 as a promising target for cytotoxicity T cells in human melanoma therapy. PLoS One. 2013,8 (8):e73261.SCI
11. J Ma#, Usui Y#*, Takeuchi M, Okunuki Y, Kazuka T, Zhang L, An X, Mizota A, Goto H.Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1. Experimental Eye Research. 2012,96 (1):98-106.SCI
12. J Ma, Y Usui, K Takeda, N Harada, H Yagita, K Okumura, H Akiba*. Tim-1 signaling in B cells regulates antibody production. Biochemical and Biophysics Research Communications. 2011,406 (2): 223-228.SCI
13. L Zhang#, J Ma#, M Takeuchi, Y Usui, T Hattori, Y Okunuki, N Yamakawa, T Kazuka*, H Goto*.Activation of aryl hydrocarbon receptor suppresses experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells. Investigative Ophthalmology Visual Science. 2010,51 (4）:2109-2117.SCI
14. J Ma#, Y Usui#*, M Takeuchi, Y Okunuki, T Kazuka, L Zhang, A Mizota, H Goto.Human uveal melanoma cells inhibit the immunostimulatory function of dendritic cells. Experimental Eye Research . 2010,91（4）:491-499.SCI
主编或副主编的著作/译著
重要奖项
1. 以B7-H3作为肿瘤靶点的T细胞治疗人类癌症的研究 北京世纪坛医院科学技术进步奖 二等奖 201705